Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-tomoderate hypertension: An 8-week, multicenter, randomized, open-label, Phase IV clinical study
Seung Hwan Han, Gyu Chul Oh, Hyuck Moon Kwon, Chang Gyu Park, In Jai Kim, Gyo Seung Hwang, Byung Su Yoo, Seong Hoon Park, Kwang Je Lee, Hyo Soo Kim
Dive into the research topics of 'Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-tomoderate hypertension: An 8-week, multicenter, randomized, open-label, Phase IV clinical study'. Together they form a unique fingerprint.